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Abstract
Background: Extracellular superoxide dismutase (SOD3), which dismutates superoxide anion to hydrogen peroxide, has
been shown to reduce the free radical stress derived apoptosis in tissue injuries. Since both superoxide anion and hydrogen
peroxide have a marked impact on signal transduction pathways and could potentially explain a number of apoptosis and
survival -related phenomena in different pathological conditions, we clarified the impact of SOD3 on Akt and Erk1/2 cell
survival pathways in rat hind limb injury model.
Methodology and Principal Findings: Based on our data, the hind limb ischemic rats treated with virally delivered sod3
have milder injury and less apoptosis than control animals that could be due to parallel activation of pro-proliferative and
anti-apoptotic Erk1/2 and Akt pathways. The common downstream factor of both signaling pathways, the apoptosis related
forkhead box protein O3a (FoxO3a), was phosphorylated and translocated to the cytoplasm in sod3 treated tissues and cell
line. Additionally, we obtained increased mRNA production of elk-1, ets-1, and microRNA 21 (miR-21), whereas synthesis of
bim mRNA was decreased in sod3 overexpressing tissues. We further showed that overexpression of sod3 modulated redox
related gene expression by downregulating nox2 and inos when compared to injured control animals.
Conclusions and Significance: The study shows the complexity of SOD3-derived effects on tissue injury recovery that are
not limited to the reduction of superoxide anion caused cellular stress but highlights the impact of SOD3 related signal
transduction on tissue functions and suggests an important role for SOD3 in attenuating cell stress effects in different
pathological conditions.
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Introduction
Tissue ischemia induces rapid generation of reactive oxygen
species (ROS) including superoxide (O2
2N), hydrogen peroxide
(H2O2),and theirderivatives, whichalong with acutelackofnutrient
supply and disturbed cellular respiration cause severe damage to
tissues. Extracellular superoxide dismutase (SOD3) is an antiox-
idative enzyme that converts superoxide into hydrogen peroxide
therebyreducingoxidativecellstress[1,2].Theenzymeissecretedto
extracellularspacewhereitreversiblybindstocellmembraneatlipid
rafts and therefore has a local impact on inactivation of
phosphotyrosine phosphatases PTP1B and DEP1 [3]. In prolonged
disease conditions, such as coronary artery disease, sod3 expression is
decreasedinatime-dependentmanner[4–6]suggestingthatthe lack
of the enzyme could deteriorate the condition. This is further
supported by the data showing that sod3 overexpression has
beneficial effects on the healing of cardiovascular injuries [7–10].
We have recently shown SOD3 to have a pro-proliferative effect in
ischemic skeletal muscle, which is caused by SOD3-derived
activation of the Ras-Erk1/2 mitogenic pathway and consequent
increased growth factor expression [8] that partially elucidate the
SOD3-mediated survival effect. Since the increased proliferation
alone may not adequately explain the therapeutic effects caused by
SOD3 and, more importantly, since previous studies have shown
significantly decreased apoptosis after sod3 overexpression [7,9], we
focused in the present work on the mechanisms of SOD3-mediated
reduced apoptosis in cardiovascular ischemia.
Based on our data, sod3 overexpression caused activation of
Erk1/2 and Akt pathways involving cytoplasmic entry of FoxO3,
increased miR-21 production, and decreased BCL-2 interacting
mediator of cell death (bim) mRNA synthesis. The study suggests
an important role for SOD3 in regulation of cellular signaling
networks and a central impact on reduced injury development and
apoptosis.
Materials and Methods
Rat hind limb ischemia model
Acute ischemic hind limb injury was induced in male Fischer
344 rats (5–6 weeks, 86–115g) by surgical ligation of distal femoral
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artery. The procedure was performed under anesthesia by single
intraperitoneal injection of fentanyl fluanisone (370 mg/100 g;
Janssen Pharmaceutica, Beerse, Belgium), and midazolame
(180 mg/100 g; Roche, Basel, Switzerland). Adequacy of the
anesthesia was determined based on the reactions of the animal
during the surgery. Animals were recovering from the anesthesia
in a separate pre-warmed environment. Immediately after ligation
adenoviral vectors carrying rabbit sod3 or LacZ control genes, both
0.5610
9 pfu in 50 ml PBS, were injected at 5 sites into the hind
limb muscles before suturing the wound. Uninjured muscle was
used as a control. The animals were followed for 3, 7 and 10 days
(4 animals in normal control, LacZ and SOD3 groups each). All
animal procedures were approved by the Southern Finland
Regional Experimental Animal Committee (License STH350A),
and done according to the European Commission and University
of Turku guidelines.
Immunohistochemistry
The thigh muscles were cut crosswise, snap frozen in 2-
methylbutane and embedded in Tissue-Tek Optimal Cutting
Temperature compound (Sakura Finetek, Torrance, CA, USA).
Ten micrometer cryosections were fixed in acetone and stained with
hematoxylin/eosin (Sigma, St. Louis, MI, USA) according to the
standard protocol, and photographed digitally with Zeiss Axiovert
200 M microscope and the AxioVision program (Carl Zeiss,
Oberkochen, Germany). The injured area as percentage of the whole
section was determined from 7 sections per group independently by
three investigators using inflammatory cell invasion, increased
connective tissue formation, and fragmentation of the muscle fibers
as criteria for injury analysis. The injured muscle tissue area was
calculated by determining the area (%) of the tissue section containing
inflammatory cells or morphological damages as compared to
inflammatory cell free tissue or tissue that did not show muscle fiber
fragmentation of connective tissue. The final injured region was
calculated from triplicate analyses (the analysis of three investigators).
Western blot analysis
Pooled rat muscle tissue from each group was homogenized
with a Retsch MM400 mixer mill using metal beads (Retsch
GmbH, Haan, Germany) in lysis buffer (50 mmol/l HEPES
pH 7.5, 150 mmol/l NaCl, 10% glycerol, 1% Triton X-100,
1 mmol/l MgCl, 10 mmol/l NaF, 10 mmol/l sodium pyrophos-
phate, 1 mmol/l Na3VO4, 10 mmol/l approtinin, 10 mg/ml
leupeptin) (Sigma). Antibodies for cleaved caspase-3 (Asp175), p-
Akt (Ser473), Akt, p-Erk1/2 (Trh202/Tyr204), Erk1/2, p-FoxO3a
(Ser318/321), p-FoxO3a (Thr32), tubulin (Cell signaling, Danvers,
MA, USA), and SP-1 (Santa Cruz, Santa Cruz CA, USA) were
used to detect the designated proteins from the blotted samples.
Cell culture and cell fractionation
NIH 3T3 cells (ATCC, Teddington, UK) were grown in
DMEM 10% CS (Sigma) with penicillin-streptomycin (Sigma).
Empty pcDNA3 control vector or human SOD3 cDNA (a kind gift
from professor Stefan L. Marklund, University of Umea ˚, Sweden)
subcloned into the pcDNA3 plasmid, were stably transfected using
Fugene 6 (Roche, Mannheim, Germany). The cells were grown in
the presence of geneticin (Sigma) and prepared for cell
fractionation. Nuclear and cytoplasmic fractions of the cells were
isolated using NE-PER Cell Fractionation kit (Thermo Scientific,
Waltham, MA, USA). The cells were lysed with the NE-PER
nuclear and cytoplasmic extraction reagents. The fractionated
proteins were loaded on SDS gels according to the standard
procedures.
Real-time quantitative PCR
Total RNA was extracted from pooled muscle samples of each
animal group with Tri-reagent (Sigma). Complementary DNA
synthesis was done with Revert-Aid M-MuLV (Fermentas,
Burlington, Canada) and the quantitative PCR with SYBR Green
master mix reagent (Applied Biosystems, Foster City, CA, USA).
Primers were: rat beta-actin forward 59-TCGTGCGTGACAT-
TAAGGAG-39 and reverse 59-GTCAGGCAGCTCGTAGC-
TCT-39; endogenous rat sod3 forward 59-GAC CTG GAG ATC
TGG ATG GA-39 and reverse 59-GTG GTT GGA GGT GTT
CTG CT-39; exogenous rabbit sod3 forward 59-GTT GCG TGA
GCG GAA AGA TG-39 and reverse GTG AGC GCC TGC
CAG ATC TC; nox2 forward 59-TTG TTG CAG GAG TGC
TCA TC-39 and reverse 59-CTG CCA GCA GGT AGA TCA
CA-39; inos forward 59-GGT GCA GAA GCA CAA AGT CA-39
and reverse 59-GAA CTG GGG GAA ACC ATT TT-39; elk-1
forward 59-AGC GGC CAG AAG TTT GTC TA-39 and reverse
59-CTG TCA TTC CTG CAC CCT TT-39; ets-1 forward 59-
GAA ATG ATG TCC CAG GCA CT-39 and reverse 59-CTT
TAC CCA GGG CAC ACA GT-39; bim forward 59-ATC TCA
GTG CAA TGG CTT CCA-39 and reverse 59-GCT CCT GTG
CGA TCC GTA TC-39; miR21 and RNU5 miScript Primer
Assays (Qiagen, Hilden, Germany) were used to study the
amplification and to normalize the miR-21 expression.
Statistical analyses
The experiments were repeated at least three times. All results
are expressed as mean 6SD. The p-values (*=p,0.05,
**=p,0.01, ***=p,0.001) were determined by one-way Anova
with Tukey-Kramer multiple comparison post-analysis test.
Results
SOD3 attenuates ischemic injury
Previously SOD3 has been shown to have growth regulatory
[8], anti-inflammatory [11], anti-oxidative [2], and anti-apoptotic
[7,9] characteristics. Since the latter is not well characterized, in
the present study we focused on sod3 overexpression-mediated
cellular signaling events leading to decreased apoptotic signaling in
ischemic tissue injury.
To justify that the in vivo model used in the study is applicable
for the present aims we first determined the relative sizes of injured
tissue areas from the histological cryo sections. We observed
significantly smaller injury regions in sod3-treated animals as
compared to control rats on 3-day (53% lower value, p,0.05) and
on 7-day (40% lower value, p,0.05) time points (Figure 1A-C). To
further characterize the effect of SOD3 and to verify whether the
enzyme has an impact on modulating apoptosis in our model, we
performed a cleaved caspase-3 Western blot that showed increased
apoptotic activity in lacz control animals as compared to sod3-
treated rats at 3-day and at 7-day time points (Figure 1D).
Since it has been reported that the cardiovascular damages are
characterized by reduced sod3 expression [4–6] we analyzed the
expression of endogenous rat sod3 mRNA in ischemic skeletal
muscle from the control animals at different time points. At 3-day
time point there was an initial increase in sod3 mRNA synthesis
that was followed by 2-fold (p,0.05) reduction at 7-day time point
and 10-fold reduction (p,0.001) at 10-day time point as compared
to normal uninjured muscle (Figure 1E). The down-regulation of
endogenous sod3 expression in injured tissues was paralleled by
increased levels of pro-inflammatory molecules, such as NADPH
oxidase 2 (nox2) and inducible nitric oxide synthase (inos) that, as
previously shown [9,12,13] can be modulated by sod3 overexpres-
sion. The injury-related marked increase in nox2 and inos mRNA
SOD3-Regulated Apoptosis
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into the ischemic injury region [14]. However, the expression of
both enzymes was significantly (p,0.01 and p,0.001, respective-
ly) attenuated by sod3 overexpression as compared to lacz control
muscles. These observations from animal tissues indicate that
SOD3 overexpression has a significant impact on tissue injury
related gene expression.
Erk1/2 pathway is the principal pathway in SOD3-
mediated tissue recovery
To explain the reduced injury development and reduced
apoptosis in our hind limb injury model we next studied the cell
survival signaling pathways that become activated in sod3-treated
tissues. Since we have previously proved that sod3 is able to
modulate the activation of Ras-Erk1/2 signaling pathway [8],
which is a major regulator of cell growth and survival, we verified
the level of Erk1/2 phosphorylation in injured control and sod3
treated animals as compared to uninjured tissues. Figure 2A shows
that the injury itself is causing an increase of phospho-Erk
signaling, and that this effect is significantly up-regulated by Sod3
treatment at 3-day (p,0.001), 7-day (p,0.05), and 10-day
(p,0.001) time points. We further investigated the effect of
SOD3 in modulating the activity of Erk1/2 pathway by
monitoring its downstream target transcription factors Elk-1 and
Ets-1 [15,16]. Both elk-1 and ets-1 expressions were significantly
(p,0.01 and p,0.001, respectively) increased in sod3 animals as
compared to LacZ controls (Figure 2B–C). Interestingly, the injury
itself had a minor effect on the synthesis of these two transcription
Figure 1. SOD3 overexpression affects tissue injury development and modifies redox enzyme expression. (A) Sod3 transduced
ischemic muscle tissues had significantly lower injury score at 3-day (p,0.05 (*)) and at 7-day (p,0.05 (*)) time points. White bars refer to lacz control
animals and black bars to sod3 transfected rats. (B) Corresponding hematoxylin/eosin staining showed increased fibrosis in LacZ control animals in
different time points as compared to SOD3 treated muscles. (C) The edges of the injured region were clearly visible. The left panel shows
hematoxylin/eosin staining of normal uninjured (*) tissue region and injured fragmented (**) muscle section. In the right panel there is an
inflammatory cell free region (#) and heavily positive CD68 inflammation muscle area (##). Since the fragmented and inflammatory cell positive
regions were partially different the injured muscle tissue area was analyzed using both parameters separately. (D) Western blot with cleaved caspase-
3 (17 kDa and 19 kDa) antibody indicated increased apoptosis at 3-day and 7-day time points in LacZ control animals as compared to sod3 treated
animals. (E) Rat endogenous sod3 mRNA expression (open bars) was downregulated at 7-day and 10-day time points (p.0.05 (*) and p,0.001 (***),
respectively). The overexpression of transgene sod3 (line) was highest 3 days after the gene transfer and reduced to background levels by the day 10.
The left Y-axis refers to relative endogenous sod3 and the right Y-axis relative transgene sod3 expression. (F) Ischemic injury caused significantly
(p,0.001) increased nox2 mRNA expression as compared to normal uninjured control animals. Sod3 overexpression attenuated the increase causing
a significant (p,0.01 (**)) reduction of nox2 expression as compared to 3-day LacZ control animals. (G) Injury-related increased (p,0.001 (***)) inos
expression was significantly (p,0.001 (***) decreased by sod3 expressing tissues.
doi:10.1371/journal.pone.0024456.g001
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PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e24456Figure 2. The effect of SOD3 on Erk1/2 signaling pathway. (A) Western blot analysis showed increased Erk1/2 phosphorylation in sod3
transduced muscles at 3-day, 7-day, and 10-day time points (p,0.001 (***), p,0.05 (*), and p,0.001 (***), respectively) as compared to
corresponding lacz controls. The samples were normalized with total Erk1/2 antibody. Erk1/2 activation was supported by significant up-regulation of
its downstream transcription factors (B) elk-1 (p,0.01 (**)) and (C) ets-1 (p,0.001 (***)), measured by mRNA synthesis in sod3 animals as compared to
SOD3-Regulated Apoptosis
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in the prolonged activation of mitogenic signal transduction routes
controlling cell proliferation and tissue recovery. We then focused
on the effect of SOD3 on the regulation of PI3K/Akt anti-
apoptotic pathway to determine the reduced caspase-3 cleavage
observed in sod3 treated animals by investigating phosphorylation
of Akt in injured tissues. Our results showed that sod3 stimulated
phosphorylation of Akt was visible only at early time point (3 days
after the injury) (Figure 2D), whereas the simultaneous effect on
Erk1/2 phosphorylation was long-lasting (up to 10 days)
(Figure 2A).
SOD3-mediated anti-apoptotic signaling
It has been shown that co-operative action of Akt and Ras-
Erk1/2 signaling cascades mediate anti-apoptotic and pro-
proliferative signals by e.g. causing FoxO3a phosphorylation,
inactivation and consequent cytoplasmic entry [17,18] that in
ischemic tissues has been reported to result in reduction of
transcriptional effect on FoxO3a target genes [19]. We therefore
investigated whether SOD3, by modulating Erk1/2 and Akt
activation, could also affect FoxO3a phoshorylation status. Based
on our current data SOD3 causes increased FoxO3a phosphor-
ylation at 3-day time point (Figure 3A). Since phosphorylation
determines the nuclear/cytoplasmic location of FoxO3a activity,
we further characterized the SOD3-derived effect on FoxO3a
localization in NIH 3T3 cells. The cells were stably transfected
with SOD3 or control eukaryotic expression vector, fractionated
to separate nuclear and cytoplasmic compartments, and
analyzed by Western blotting. According to our results sod3
transfected cells had markedly (p,0.05) more phosphorylated
total FoxO3a, and interestingly the amount of phosphorylated
protein was significantly (p,0.001) enriched in the cytosolic
compartment as compared to control vector transfected cells
(Figure 3B). To determine the effect of SOD3 on the total
amount of FoxO3a, we then performed a real time PCR analysis
and found that SOD3 expressing cells (Figure 3C) had similar
levels of foxo3a mRNA as compared to control cells (Figure 3D),
suggesting that SOD3 is mainly influencing the phosphorylation
levels and consequent cytoplasmic entry of FoxO3a, but not the
total protein amount.
Since it was recently shown that in the nucleus FoxO3a
suppresses the anti-apoptotic miR-21 transcription [20,21] we next
analyzed the microRNA (miRNA) expression. Based on the
quantitative real time-PCR data, the expression of mir-21 in sod3
overexpressing ischemic tissues at 3-day time point was signifi-
cantly (p,0.001) increased as compared to uninjured control
muscles. Even though the injury itself had an activating effect on
miRNA expression (p,0.05) sod3 was able to significantly
(p,0.01) further increase it as compared to LacZ injured control
tissues (Figure 3E). To characterize another FoxO3a downstream
target we then checked the mRNA expression of pro-apoptotic
bim, which is known to be downregulated by coordinated action of
Akt and Erk1/2 [22–24]. As shown in figure 3F, the injury-related
increased (p,0.01) bim mRNA expression was significantly
(p,0.01) decreased in sod3 tissues thereby indicating that the
SOD3-derived activation of Akt in coordination with Erk1/2
signal transduction routes may represent a key mechanism to
reduce the apoptotic response in tissues.
Discussion
The skeletal muscle ischemia induces production of ROS by the
disrupted metabolism and by the infiltrating inflammatory cells,
such as macrophages. The physiological function of SOD3 is to
convert superoxide anion to hydrogen peroxide on the extracel-
lular side of the cell membrane [1,2] relieving the free radical
superoxide anion derived damages in the tissue environment.
However, this reaction leading to reduced oxidative stress does not
explain per se the decreased apoptosis seen in SOD3 overexpressing
tissues. Therefore, our purpose in the current work was to clarify
the PI3K-Akt and Erk1/2 response caused by SOD3 in apoptosis
model.
Based on the current data the significantly increased nox2 and
inos mRNA expressions together with decreased sod3 expression at
later time points (Figure 1E–G) suggest a marked imbalance in
redox enzyme expression levels in developing tissue injury.
Previously, we have shown that sod3 gene transfer to ischemic
hind limb injury is able to increase the active SOD3 concentration
in the tissue by 2-fold [8], which together with the remarkably long
half-life of the enzyme in the muscle tissue, up to 100 hours [25],
would be able correct the decrease of the endogenous enzyme
expression causing the therapeutic response. The current analysis
of the effect of sod3 overexpression on the apoptosis (Figure 1D)
was in line with previous reports demonstrating the anti-apoptotic
role of the enzyme [7,9] further suggesting SOD3-derived
response on cell survival signaling.
Among the anti-apoptotic and pro-survival pathways that are
activated after ischemic injuries, the PI3K-Akt and Erk1/2 routes
are considered to be the most important. The numerous substrates
of these kinases include several apoptosis-related factors such as
Foxo3a and caspases, which are affected by Akt and/or Erk
phosphorylation [17,18,26–28]. The interplay between SOD3 and
Akt has been confirmed previously in an in vitro experiment in
which sod3 transfection increased phospho-Akt levels in cells but
not at late time point in rat tissues [8]. In the present work, we
found notably increased level of sod3 promoted Akt phosphory-
lation at early phase of the injury that, however, was lost at later
phase unlike Erk1/2, suggesting milder SOD3-related stimulation
to PI3K-Akt than Erk1/2 signaling. To further strengthen the role
of Erk1/2 in cell survival we showed upregulation of ets-1 and elk-1
transcription factors in sod3 treated animals as compared to
controls (Figure 2B–C), which let us to speculate that the earlier
robust Erk1/2 activation induced by SOD3 continuously boosts
the ets-1 and elk-1 expression, lifting it to a significantly higher level
than in the control animals.
One of the direct Erk1/2 and Akt target proteins, the ROS
responsive transcription factor FoxO3a, regulates the expression of
many cell cycle arrest- and apoptosis-related genes [29–32] and is
alsoknown to protectnormalquiescentcells from oxidativestressby
regulatingseveralantioxidantgenese.g.peroxiredoxins,glutathione
peroxidases, and superoxide dismutases including SOD3 [33–35].
We discovered increased FoxO3a phosphorylation in sod3 treated
animalsat day3 after the ischemic injury, which was then decreased
to the level of the control animals (Figure 3A). The effect of sod3
overexpression on FoxO3a phosphorylation and cytoplasmic entry
was confirmed in sod3 stable NIH3T3 cell line that demonstrated
increased phosphorylation of the transcription factor while the total
amount of foxo3a remained unaffected (Figure 3B–D).
LacZ control tissues. The injury itself moderately increased production of both molecules as compared to normal uninjured tissue control. However,
the significant difference between normal control tissue and LacZ control (p,0.05 (*)) was achieved only in ets-1 expression. (D) Sod3 transduced
muscles have increased levels of Akt phosphorylation only at 3-day time point (p,0.001 (***)). The samples were normalized with total Akt antibody.
doi:10.1371/journal.pone.0024456.g002
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e24456Figure 3. SOD3-mediated anti-apoptotic signaling. (A) The phosphorylation of FoxO3a (Thr32) in sod3 treated muscle tissues was strongly up-
regulated at 3-day time point, had non-significant tendency at 7-day time point and showed no difference to LacZ control tissues at 10-day time
point. The blot was normalized with tubulin antibody. (B) In vitro cell fractionation assay showed increased phosphorylation of FoxO3a in SOD3 stably
transfected NIH 3T3 cells. The amount of phosphorylated protein was significantly (p,0.05 (*)) higher in the total cell extract and was enriched in the
cytoplasmic fractions (p,0.001 (***)) of cells transfected with SOD3 when compared to control cells. Normalization was performed by using a-SP1
antibody for the nuclear fractions and a-tubulin antibody for the cytoplasmic fraction. For statistical analysis cytosol, nucleus, and total protein
compartments were compared between control and SOD3 samples. (C–D) To determine the effect of SOD3 on the amount of total FoxO3a, we
measured in NIH3T3 cells stably transfected with SOD3 (panel C) the mRNA synthesis of foxo3a (panel D) that showed no difference to control cells.
(E) To verify whether FoxO3a targets were also regulated by SOD3 we then performed expression analysis for mir-21 in rat tissues showing
significantly (p,0.05 (*)) increased miRNA synthesis caused by the ischemic injury that was further induced by sod3 overexpression (p,0.01 (**)) as
compared to LacZ control animals). (F) Similarly, also the expression of bim, which is another target of FoxO3a, was found to be modulated by SOD3,
as its expression was significantly stimulated (p,0.01 (**)) due to ischemia and then decreased by sod3 overexpression (p,0.01 (**)).
doi:10.1371/journal.pone.0024456.g003
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apoptotic microRNA, mir-21 by binding the mir-21 promoter to
suppress its expression [21]. In line with this, we demonstrated
increased mir-21 expression in vivo in sod3-transduced tissues
(Figure 3E). Next, to confirm that sod3 is affecting FoxO3a
function we monitored the inhibition of bim, another common
downstream target of Akt and Erk1/2 pathways. BH3-only
proteins, such as BIM, are cell death initiators that are activated
in cellular stress conditions including response to DNA damages,
decreased metabolism, growth factor withdrawal, and hypoxia.
Based on our results the significantly (p,0.01) decreased
expression of bim mRNA production correlated with sod3
overexpression in muscles suggesting that SOD3-derived increased
FoxO3a phosphorylation at 3-day time point might be able to
attenuate the initiation of the apoptotic process by BH3-only
protein BIM (Figure 3F).
In summary, we have elucidated the signaling events by which
the extracellular sod3 promotes cell survival and tissue recovery in
skeletal muscle ischemia model (Figure 4). The overexpression of
sod3 correlated with simultaneous activation of Akt and Erk1/2,
consequent FoxO3a cytoplasmic entry, anti-apoptotic mir-21
upregulation and pro-apoptotic bim mRNA downregulation. On
the tissue level, sod3 overexpression attenuated the injury
development and decreased apoptosis. Therefore, the present
data support our previous findings connecting the Erk1/2
mitogenic signaling cascade and downstream effectors to sod3
expression and cell survival effects.
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